Earnings Call · Q2 FY2024·2024-08-08

Q2 24EPS -100.00%*·Rev n/aQ1 24EPS +33.33%·Rev n/aQ4 23EPS +100.00%*·Rev n/aQ3 23EPS -100.00%*·Rev n/a⚠ consensus missing

MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI

Deborah Hart — Chief Financial Officer

Trey Martin — Chief Executive Officer

Kevin Herde — Chief Financial Officer

−6.9%1d on move date−9.2% vs SPY3d−4.4%5d−9.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MRVI calls or request research access.

More MRVI calls Browse calls Request research access